Crucell N.V. Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Crucell N.V.'s estimated annual revenue is currently $21.2M per year.(i)
  • Crucell N.V.'s estimated revenue per employee is $155,000

Employee Data

  • Crucell N.V. has 137 Employees.(i)
  • Crucell N.V. grew their employee count by -14% last year.

Crucell N.V.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Crucell N.V.?

Biotechnology; Pharmaceuticals

keywords:N/A

N/A

Total Funding

137

Number of Employees

$21.2M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Crucell N.V. News

2022-04-19 - Global Tratamiento de la infección por H3N2 Mercado Análisis ...

AIMM Therapeutics BV, Aphios Corporation, Crucell NV, CSL Limited, Glide Pharmaceutical Technologies Limited, ILiAD Biotechnologies LLC,...

2022-04-17 - Influenza Virus Vaccine (H1N1) Market Size And Forecast | Butantan ...

... Biological Engineering Inc, Cantacuzino Institute Of Sera And Vaccines, Changchun Institute Of Biological Products And Crucell N.V..

2022-02-22 - Global HIV Vaccines Market Research Report to 2027 - Featuring AlphaVax, Crucell and Novartis Among Others - ResearchAndMarkets.com

Global HIV Vaccines Market Research Report to 2027 - Featuring AlphaVax, Crucell and Novartis Among Others - ResearchAndMarkets.com.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.3M1375%N/A
#2
$17.8M137-14%$115.9M
#3
$34.3M137-6%N/A
#4
$17.8M1370%$34M
#5
$15M1377%N/A